Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New HIV protease inhibitors disclosed by Merck & Co.

Feb. 20, 2015

No Comments

Novel anti-HIV agent shows potential as HIV vaccine alternative

Feb. 20, 2015

No Comments

NeED Pharma presents new viral entry inhibitors

Feb. 12, 2015

No Comments

Gilead presents new anti-HIV compounds

Feb. 6, 2015

No Comments

CytoDyn concludes phase II PRO-140 trial and submits phase III protocol to FDA

Feb. 5, 2015

No Comments

Prezcobix approved in the U.S. for the treatment of adults with HIV-1

Feb. 2, 2015

No Comments

EMA CHMP recommends approval of lamivudine/raltegravir for HIV-1 infection

Jan. 27, 2015

No Comments

Laboratoire Biodim tests novel agents for HIV

Jan. 21, 2015

No Comments

New data on the effect of PennVax-B in HIV-1-infected adults

Jan. 21, 2015

No Comments

AB Science patents new SCFR inhibitors

Jan. 14, 2015

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

HIV/AIDS
RSS

New HIV protease inhibitors disclosed by Merck & Co.

Novel anti-HIV agent shows potential as HIV vaccine alternative

NeED Pharma presents new viral entry inhibitors

Gilead presents new anti-HIV compounds

CytoDyn concludes phase II PRO-140 trial and submits phase III protocol to FDA

Prezcobix approved in the U.S. for the treatment of adults with HIV-1

EMA CHMP recommends approval of lamivudine/raltegravir for HIV-1 infection

Laboratoire Biodim tests novel agents for HIV

New data on the effect of PennVax-B in HIV-1-infected adults

AB Science patents new SCFR inhibitors

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

HIV/AIDS RSS

HIV/AIDS
RSS